Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates
Featuring perspectives from Prof Marina Chiara
Garassino, Dr John V Heymach, Prof Solange Peters and Dr Jacob
Sands, moderated by Dr Sands, including the following topics:
Introduction (0:00)
Role of Immune Checkpoint Inhibitors in Metastatic Non-Small
Cell Lung Cancer (NSCLC) without a Targetable Tumor Mutation — Prof
Peters (2:07)
Targeted and Other Novel Therapeutic Strategies for Relapsed
Metastatic NSCLC — Prof Garassino (26:30)
Potential Role of TROP2-Targeted Antibody-Drug Conjugates in
Advanced NSCLC — Dr Sands (50:19)
Evolving Role of Immune Checkpoint Inhibitors in the Care of
Patients with Nonmetastatic NSCLC — Dr Heymach (1:12:36)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.